Mikail Gögenur

9PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Dec 18, 2025
Refined Algorithm for Identifying Recurrence Among Patients with Non-Metastatic Colorectal Cancer Based on Danish National Health Data Registries.

Mikail Gögenur, Karoline Bendix Bräuner, Lea Löffler

|Sep 18, 2025
Clinical implementation of an AI-based prediction model for decision support for patients undergoing colorectal cancer surgery.

Andreas Weinberger Rosen, Ilze Ose, Mikail Gögenur

|May 12, 2023
Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial.

Mikail Gögenur, Lukas Balsevicius, Mustafa Bulut

|Aug 06, 2022
ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis.

Mikail Gögenur, Noor Al-Huda Hadi, Camilla Qvortrup

|Aug 05, 2022
ASO Author Reflections: Is ctDNA Detection an Accurate Measure of the Risk of Recurrence in Patients Undergoing Neoadjuvant Treatment?

Mikail Gögenur, Claus Lindbjerg Andersen, Ismail Gögenur

Pageof 2

Frequent Collaborators

2 joint publications

Ismail Gögenur

1 joint publications

Tina Fransgård

1 joint publications

Andreas Weinberger Rosen

1 joint publications

Ilze Ose